Penumbra 3D trial results to be presented at SNIS 2016

561

Penumbra logo

Penumbra has announced its schedule of key events at the Society of NeuroInterventional Surgery (SNIS) 13th Annual Meeting (July 25-28 2016, Boston, USA).  These events include the presentation of the results of the randomised controlled clinical trial for the company’s next generation stent retriever, the Penumbra 3D revascularisation device.

The results of this trial will be presented during the Late Breaking Abstract Presentations session on July 27 by Donald Frei, of Radiology Imaging Associates/Swedish Medical Center (Denver, USA).

The Penumbra 3D trial is a prospective, non-inferiority study comparing the safety and efficacy of the Penumbra 3D revascularisation device used in conjunction with Penumbra system aspiration devices with that of Penumbra system aspiration devices alone.

The company will also feature its latest products at lunchtime presentations to be held Monday, July 25, Wednesday July 27 and Thursday July 28.

Penumbra will also sponsor a public awareness event organised by The Joe Niekro Foundation and The Bee Foundation on Tuesday, July 26, during the Boston Red Sox vs Detroit Tigers baseball game at Fenway Park in Boston. The event will pay tribute to those lost to stroke, and honour survivors, with the aim of increasing visibility and awareness of stroke and its impact on patients and their families.

(Visited 64 times, 1 visits today)